A  Mid-Atlantic Angel Group

http://www.magfund.com





     Office Locations:

Building 100 Innovation Center
4801 S. Broad Street, Suite 200
Philadelphia, PA 19112
Phone: 215-972-6700

 

Stages:

  • Early
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Manufacturing & Industrial
  • Software & Internet

  •  

    Description:

    The Mid-Atlantic Angel Group Funds I & II, LP (MAG I & II) were created to bridge the gap between angel funding and institutional venture capital funding serving the Greater Philadelphia Region. These member-managed funds provide investors with an opportunity for active involvement in diversified venture capital investments throughout Pennsylvania, New Jersey, Delaware, New York, and Maryland. The funds seek to leverage various public and private funding resources and networks by providing equity capital to seed and early-stage, technology-based, high-growth companies. MAG I was formed in January 2005 and has completed investments in 12 companies and has 89 angel and institutional investors. MAG I has completed its funding cycle. MAG II was formed in April 2009 and has 65 angel and institutional investors and is actively seeking to make investments.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Jeff Snellenburg Executive Director
    Justin Hanley Analyst

     

    Portfolio companies include:


      AboutOne
        web link


      Andante Medical Devices
        web link


      Biopticon
        web link


      Carnegie Speech Company
        web link


      Cloudmine
        web link


      Compliance Assurance
        web link


      Detect-Ready
        web link


      Immunome
        web link


      Molecular Detection
        web link


      Nanopack
        web link


      Novira Therapeutics
        web link


      OneTwoSee
        web link


      Protez Pharmaceuticals
        web link


      Sidecar E-Commerce
        web link


      SideCar Technologies
        web link


      TicketLeap
        web link


      vcopious
        web link


      WizeHive
        web link


      Yaupon Therapeutics
        web link


     

    Recent News:


      There is no recent news for Mid-Atlantic Angel Group.